Skip to main content

 Related scientific articles (all)

A rare case of a pancreatic mass due to accessory spleen; when EUS-FNA is not enough.

Authors : Toussaint E, Flamen P, Demetter P, Matos C, Van Gossum M, Delhaye M, Closset J, Loi P, Deviere J, Arvanitakis M
Year : 2011
Journal : Endoscopy
Volume : 43 Suppl 2 UCTN(null)
Pages : E221-2

The Research Ethics Committee at Universidade Federal de Santa Maria: a brief historical review

Authors : Nardin Weis L, Hundertmarck Minato E, Borges Fagundes R, Bins di Napoli R, Emando Silva C, de Campos Velho MTA, Dal Lago L
Year : 2011
Journal : Revista HCPA
Volume : 31(3)
Pages : 372-76

Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?

Authors : Aftimos P, Awada A
Year : 2011
Journal : Adv Ther
Volume : 28(11)
Pages : 973-85

Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.

Authors : Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P, Buvat I
Year : 2011
Journal : J. Nucl. Med.
Volume : 52(3)
Pages : 354-61

Envelhecimento e doença crônica - editorial

Authors : Dal Lago L
Year : 2011
Journal : Revista da AMRIGS, Porto Allegre
Volume : 55(1)
Pages : 5-6p

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.

Authors : Journe F, Id Boufker H, Van Kempen L, Galibert MD, Wiedig M, Sales F, Theunis A, Nonclercq D, Frau A, Laurent G, Awada A, Ghanem G
Year : 2011
Journal : Br J Cancer
Volume : 105(11)
Pages : 1726-32

HER2-positive circulating tumor cells in breast cancer.

Authors : Ignatiadis M, Rothé F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C, Metallo J, Kheddoumi N, Singhal SK, Michiels S, Veys I, Rossari J, Larsimont D, Carly B, Pestrin M, Bessi S, Buxant F, Liebens F, Piccart-Gebhart M, Sotiriou C
Year : 2011
Journal : PLoS One
Volume : 6(1)
Pages : e15624

New development in hormone receptor-positive disease.

Authors : Piccart-Gebhart M
Year : 2011
Journal : Oncologist
Volume : 16 suppl 1
Pages : 40-50

Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).

Authors : Altintas S, Toussaint J, Durbecq V, Lambein K, Huizing MT, Larsimont D, Van Marck E, Vermorken JB, Tjalma WA, Sotiriou C
Year : 2011
Journal : Breast J
Volume : 17(4)
Pages : 343-51

Outils génomiques pouvant aider au choix thérapeutique des cancers du sein – Analyse in « Cancer du Sein : compte-rendu du 12ème Cours francophone supérieur de cancérologie – (TEXTBOOK : Nice, St-Paul de Vence, Janvier 19-22, 2011 » Namer M., Héry M.

Authors : Ignatiadis M, Sotiriou C
Year : 2011
Journal : Book
Volume : -
Pages : 311-16

Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trial.

Authors : Awada A, Gil T, Whenham N, Van Hamme J, Besse-Hammer T, Brendel E, Delesen H, Joosten MC, Lathia CD, Loembé BA, Piccart-Gebhart M, Hendlisz A
Year : 2011
Journal : J Clin Pharmacol
Volume : 51(12)
Pages : 1674-84